PPF Group acquires a minority stake in biotech company Cytune Pharma in cooperation with SOTIO.
PPF Group has acquired a significant minority stake in Cytune Pharma SAS, a French biotechnology company focused on researching and developing new therapies for immune modulation aimed at enhancing immune response of patients suffering from cancer and infectious diseases. Cytune’s platform based on modified IL-15 offers the possibility of combinations with other immunotherapeutic strategies, including checkpoint inhibitors.
February 4, 2015
Source: PPF Group N.V. – Press Release